December 1, 2014
The Ministry of Health, Labor and Welfare has designated JACE, a cultured epidermal autograft of Japan Tissue Engineering, as Japan’s first orphan regenerative medicine product. JACE is expected to be used in patients with congenital giant pigmented nevus, with the...read more